Search Results - "Juan, Todd"

Refine Results
  1. 1

    FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution by Ge, Huanying, Liu, Kejun, Juan, Todd, Fang, Fang, Newman, Matthew, Hoeck, Wolfgang

    Published in Bioinformatics (15-07-2011)
    “…Motivation: Next generation sequencing technology generates high-throughput data, which allows us to detect fusion genes at both transcript and genomic levels…”
    Get full text
    Journal Article
  2. 2

    Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer by AMADO, Rafael G, WOLF, Michael, PATTERSON, Scott D, CHANG, David D, PEETERS, Marc, VAN CUTSEM, Eric, SIENA, Salvatore, FREEMAN, Daniel J, JUAN, Todd, SIKORSKI, Robert, SUGGS, Sid, RADINSKY, Robert

    Published in Journal of clinical oncology (01-04-2008)
    “…Panitumumab, a fully human antibody against the epidermal growth factor receptor (EGFR), has activity in a subset of patients with metastatic colorectal cancer…”
    Get full text
    Journal Article
  3. 3

    Limited differential expression of miRNAs and other small RNAs in LPS-stimulated human monocytes by Lu, Daniel, Yamawaki, Tracy, Zhou, Hong, Chou, Wen-Yu, Chhoa, Mark, Lamas, Edwin, Escobar, Sabine S, Arnett, Heather A, Ge, Huanying, Juan, Todd, Wang, Songli, Li, Chi-Ming

    Published in PloS one (25-03-2019)
    “…Monocytes are a distinct subset of myeloid cells with diverse functions in early inflammatory immune modulation. While previous studies have surveyed the role…”
    Get full text
    Journal Article
  4. 4

    Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer by Sherman, Steven I, Wirth, Lori J, Droz, Jean-Pierre, Hofmann, Michael, Bastholt, Lars, Martins, Renato G, Licitra, Lisa, Eschenberg, Michael J, Sun, Yu-Nien, Juan, Todd, Stepan, Daniel E, Schlumberger, Martin J

    Published in The New England journal of medicine (03-07-2008)
    “…This phase 2 trial investigated the efficacy of motesanib diphosphate, an orally active inhibitor of VEGF receptors, in patients with advanced differentiated…”
    Get full text
    Journal Article
  5. 5

    Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia by Sasu, Barbra J., Cooke, Keegan S., Arvedson, Tara L., Plewa, Cherylene, Ellison, Aaron R., Sheng, Jackie, Winters, Aaron, Juan, Todd, Li, Hongyan, Begley, C. Glenn, Molineux, Graham

    Published in Blood (29-04-2010)
    “…Iron maldistribution has been implicated in multiple diseases, including the anemia of inflammation (AI), atherosclerosis, diabetes, and neurodegenerative…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor by Burgess, Teresa L, Sun, Jan, Meyer, Susanne, Tsuruda, Trace S, Sun, Jilin, Elliott, Gary, Chen, Qing, Haniu, Mitsuru, Barron, Will F, Juan, Todd, Zhang, Ke, Coxon, Angela, Kendall, Richard L

    Published in Molecular cancer therapeutics (01-02-2010)
    “…AMG 102 is a fully human monoclonal antibody that selectively targets and neutralizes hepatocyte growth factor/scatter factor (HGF/SF). A detailed biochemical…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A comparability study of 5 commercial KRAS tests by Oliner, Kelly, Juan, Todd, Suggs, Sid, Wolf, Michael, Sarosi, Ildiko, Freeman, Daniel J, Gyuris, Tibor, Baron, Will, Bakker, Andreas, Parker, Alex, Patterson, Scott D

    Published in Diagnostic pathology (16-04-2010)
    “…Activating mutations in the KRAS gene occur frequently in human tumors, including colorectal carcinomas; most mutations occur in codons 12 and 13. Mutations in…”
    Get full text
    Journal Article
  10. 10

    Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor by Freeman, Daniel J, Bush, Tammy, Ogbagabriel, Selam, Belmontes, Brian, Juan, Todd, Plewa, Cherylene, Van, Gwyneth, Johnson, Carol, Radinsky, Robert

    Published in Molecular cancer therapeutics (01-06-2009)
    “…Epidermal growth factor receptor (EGFR) kinase domain mutations cause hyperresponsiveness to ligand and hypersensitivity to small-molecule tyrosine kinase…”
    Get full text
    Journal Article
  11. 11

    Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors by Caenepeel, Sean, Renshaw-Gegg, Lisa, Baher, Angelo, Bush, Tammy L, Baron, Will, Juan, Todd, Manoukian, Raffi, Tasker, Andrew S, Polverino, Anthony, Hughes, Paul E

    “…Activating mutations in Kit receptor tyrosine kinase or the related platelet-derived growth factor receptor (PDGFR) play an important role in the pathogenesis…”
    Get full text
    Journal Article
  12. 12

    The Dual Specificity JKAP Specifically Activates the c-Jun N-terminal Kinase Pathway by Chen, Alice J., Zhou, Guisheng, Juan, Todd, Colicos, Suzanne M., Cannon, John P., Cabriera-Hansen, Maria, Meyer, Christian F., Jurecic, Roland, Copeland, Neal G., Gilbert, Debra J., Jenkins, Nancy A., Fletcher, Fred, Tan, Tse-Hua, Belmont, John W.

    Published in The Journal of biological chemistry (27-09-2002)
    “…The involvement of dual specificity phosphatases (DSPs) in the mitogen-activated protein kinase (MAPK) signaling has been mostly limited to the inactivation of…”
    Get full text
    Journal Article
  13. 13

    Cloning and Characterization of a Specific Receptor for Mouse Oncostatin M by Lindberg, Richard A., Juan, Todd S.-C., Welcher, Andrew A., Sun, Yu, Cupples, Rod, Guthrie, Brenda, Fletcher, Frederick A.

    Published in Molecular and Cellular Biology (01-06-1998)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64 (∗) by Juan, Todd S.-C., Hailman, Eric, Kelley, Michael J., Busse, Leigh A., Davy, Elyse, Empig, Cyril J., Narhi, Linda O., Wright, Samuel D., Lichenstein, Henri S.

    Published in The Journal of biological chemistry (10-03-1995)
    “…CD14 is a 55-kDa glycoprotein which binds lipopolysaccharide (LPS) and enables LPS-dependent responses in a variety of cells. Recent limited proteolysis…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer by Amado, Rafael G, Wolf, Michael, Peeters, Marc, Van Cutsem, Eric, Siena, Salvatore, Freeman, Daniel J, Juan, Todd, Sikorski, Robert, Suggs, Sid, Radinsky, Robert, Patterson, Scott D, Chang, David D

    Published in Journal of clinical oncology (20-06-2023)
    “…Panitumumab, a fully human antibody against the epidermal growth factor receptor (EGFR), has activity in a subset of patients with metastatic colorectal cancer…”
    Get full text
    Journal Article
  18. 18

    Identification of a Domain in Soluble CD14 Essential for Lipopolysaccharide (LPS) Signaling but Not LPS Binding by Juan, Todd S.-C., Hailman, Eric, Kelley, Michael J., Wright, Samuel D., Lichenstein, Henri S.

    Published in The Journal of biological chemistry (21-07-1995)
    “…CD14 is a 55-kDa glycoprotein that binds lipopolysaccharide (LPS) and enables LPS-dependent responses in a variety of cells. Monoclonal antibodies of CD14 such…”
    Get full text
    Journal Article
  19. 19

    Soluble CD14 Truncated at Amino Acid 152 Binds Lipopolysaccharide (LPS) and Enables Cellular Response to LPS (∗) by Juan, Todd S.-C., Kelley, Michael J., Johnson, David A., Busse, Leigh A., Hailman, Eric, Wright, Samuel D., Lichenstein, Henri S.

    Published in The Journal of biological chemistry (20-01-1995)
    “…CD14 is a 55-kDa glycoprotein which binds lipopolysaccharide (LPS) and enables LPS-dependent responses in a variety of cells. In order to identify the domains…”
    Get full text
    Journal Article
  20. 20

    Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt by Anderson, Abraham A, Helmering, Joan, Juan, Todd, Li, Chi-Ming, McCormick, Jocelyn, Graham, Melissa, Baker, Daniel M, Damore, Michael A, Véniant, Murielle M, Lloyd, David J

    Published in PathoGenetics (22-01-2009)
    “…C57BLKS/J (BLKS) mice are susceptible to islet exhaustion in insulin-resistant states as compared with C57BL6/J (B6) mice, as observed by the presence of the…”
    Get full text
    Journal Article